Staudacher Heidi Maria
Diabetes and Nutritional Sciences Division, King's College London, London, UK.
J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:16-19. doi: 10.1111/jgh.13688.
Dietary restriction of certain fermentable carbohydrates (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet) is effective for managing symptoms of irritable bowel syndrome (IBS). However, there are potential consequences of this diet that relate to its impact on nutritional, microbiological, and health-related quality of life outcomes. Evidence suggests that the low FODMAP diet leads to some alterations in nutrient intake. For example, carbohydrate intake is reduced, and there is a decrease in the proportion of patients meeting the recommended intake for calcium. Intake of other macro and micro-nutrients appears to be adequate in the short term. As well as the impact on nutrient intake, extensive dietary modification can have a pronounced impact on the gastrointestinal microbiota. Indeed, recent data suggests the diet markedly reduces luminal Bifidobacteria concentration, and there is limited evidence that it reduces total bacteria abundance and concentration of other bacterial groups, for example, Faecalibacterium prausnitzii. Finally, despite the evidence for its clinical effectiveness in patients with IBS, the restrictive nature of the diet could pose a significant burden on patients, thereby limiting improvements, or indeed worsening health-related quality of life. In conclusion, while robust evidence supports the clinical effectiveness of the low FODMAP diet, it is important, considering the likelihood of its continued widespread use in IBS and other functional bowel disorders, that we extend our understanding of the impact of the diet on endpoints that may have potential consequences for long term health.
限制某些可发酵碳水化合物的饮食(低可发酵寡糖、双糖、单糖和多元醇(FODMAP)饮食)对管理肠易激综合征(IBS)的症状有效。然而,这种饮食存在一些潜在后果,涉及它对营养、微生物和与健康相关的生活质量结果的影响。有证据表明,低FODMAP饮食会导致营养摄入出现一些变化。例如,碳水化合物摄入量减少,达到钙推荐摄入量的患者比例下降。短期内其他宏量和微量营养素的摄入量似乎充足。除了对营养摄入的影响外,广泛的饮食调整会对胃肠道微生物群产生显著影响。事实上,最近的数据表明,这种饮食会显著降低肠腔双歧杆菌浓度,而且仅有有限的证据表明它会降低总细菌丰度和其他细菌群的浓度,例如普拉梭菌。最后,尽管有证据表明其对IBS患者具有临床疗效,但这种饮食的限制性可能给患者带来重大负担,从而限制改善情况,甚至恶化与健康相关的生活质量。总之,虽然有力的证据支持低FODMAP饮食的临床疗效,但考虑到其在IBS和其他功能性肠病中可能会持续广泛使用,重要的是我们要加深对这种饮食对可能对长期健康产生潜在后果的终点指标影响的理解。